NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









EmbarkNeuro

Private
Oakland, CaliforniaHealthcare & Life Sciences

Last Round

Seed

Jun 30, 2021

Company Overview

EmbarkNeuro is a biotechnology company focused on developing personalized treatments for mental health disorders, specifically targeting the stress-response system.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Mental Health, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverymental healthmajor depressive disorderclinical trialsbiomarkervasopressin 1b receptor antagonistHPA axisprecision psychiatryneurosciencebiotech startupstress-response systempharma R&DCNS drug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EmbarkNeuro Comps

Public and private peers based on sector, stage, and business model.

EmbarkNeuro comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

EmbarkNeuro Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 30, 2021

EmbarkNeuro Investors

Notable investors and investment history

EmbarkNeuro investors
InvestorRounds
Aditum BioSeed

EmbarkNeuro Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EmbarkNeuro Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EmbarkNeuro's valuation, stock price, and market status.

Firmographic Details

HeadquartersOakland, California
Year Founded2021
Last FundingJun 30, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.